Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasis

International Journal of Colorectal Disease

Volumn 28, Issue 10, 2013, Pages 1359-1365

  Shao, Yen Chen ^a   Chang, Yu Yao ^a   Lin, Jen Kou ^a   Lin, Chun Chi ^a   Wang, Huann Sheng ^a   Yang, Shung Haur ^a   Jiang, Jeng Kai ^a   Lan, Yuan Tzu ^a   Lin, Tzu Chen ^a   Li, Anna Fen Yau ^a   Chen, Wei Shone ^a   Chang, Shih Ching ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Colorectal cancer; Metastasectomy; Neoadjuvant chemotherapy; Palliative resection

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CURATIVE RESECTION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INOPERABLE CANCER; INTERMETHOD COMPARISON; LIVER METASTASIS; LUNG METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS RESECTION; OVARY METASTASIS; OVERALL SURVIVAL; PERITONEUM METASTASIS; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR RECURRENCE; TUMOR REGRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DEMOGRAPHY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; METASTASECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884990103     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-013-1713-x     Document Type: Article

References (36)

1. The Department of Health (2007) Cancer registry annual report. The Department of Health, The Executive Yuan, Taiwan
2. Jessup JM, McGinnis LS, Steele GD Jr et al (1996) The National Cancer Data Base report on colon cancer. Cancer 78:918-926
3. Ju JH, Chang SC, Wang HS et al (2007) Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. Int J Colorectal Dis 22:855-862
4. Martin R, Paty P, Fong Y et al (2003) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197:233-241
5. Adam R, Delvart V, Pascal G et al (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240:644-657
6. Douillard JY, Cunningham D, Roth AD et al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomised trial. Lancet 355:1041-1047
7. de Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947
8. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342
9. Falcone A, Ricci S, Brunetti I et al (2007) Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 25:1670-1676
10. Van Cutsem E, KoÂ̈hne CH, Hitre E et al (2009) Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 360:1408-1417
11. Joffe J, Gordon PH (1981) Palliative resection for colorectal carcinoma. Dis Colon Rectum 24:355-360
12. Longo WE, Ballantyne GH, Bilchik AJ et al (1988) Advanced rectal cancer. What is the best palliation? Dis Colon Rectum 31:842-847
13. Nash GM, Saltz LB, Kemeny NE et al (2002) Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 9:954-960
14. Rosen SA, Buell JF, Yoshida A et al (2000) Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 135:530-534
15. Ruo L, Gougoutas C, Paty PB et al (2003) Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 196:722-728
16. Tebbutt NC, Norman AR, Cunningham D et al (2003) Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 52:568-573
17. Rosen SA, Buell JF, Yoshida A et al (2000) Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 135:530-534
18. Shimomura M, Okajima M, Hinoi T et al (2012) Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer. Int J Colorectal Dis 27:1339-46
19. Clavien PA, Petrowsky H, DeOliveira ML et al (2007) Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 356:1545-1559
20. Edge SB, Byrd DR, Compton CC et al (2010) In: AJCC cancer staging manual, 7th edn. Springer, New York
21. Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 124:979-994
22. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309-18
23. Hind D, Tappenden P, Tumur I, et al (2008) The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Health Technol Assess 12: iii-ix, xi-162
24. Folprecht G, Grothey A, Alberts S et al (2005) Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 16:1311-1319
25. Masi G, Cupini S, Marcucci L et al (2006) Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol 13:58-65
26. Simmonds PC (2000) Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 321:531-535
27. Rougier P, Milan C, Lazorthes F et al (1995) Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Francaise de Cancerologie Digestive. Br J Surg 82:1397-1400
28. National Comprehensive Cancer Network (2010) Colon cancer clinical practice guidelines in oncology. http://www.nccn.org. Accessed January 2012
29. Al-Sanea N, Isbister WH (2004) Is palliative resection of the primary tumour, in the presence of advanced rectal cancer, a safe and useful technique for symptom control? ANZ J Surg 74:229-232
30. Kleespies A, Füessl KE, Seeliger H et al (2009) Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis 24:1097-1109
31. Hurwitz H, Saini S (2006) Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events. Semin Oncol 33:S26-S34
32. Seo GJ, Park JW, Yoo SB et al (2010) Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer. J Surg Oncol 102:94-99, Jul 1
33. Costi R, Di Mauro D, Giordano P et al (2010) Impact of palliative chemotherapy and surgery on management of stage IV incurable colorectal cancer. Ann Surg Oncol 17:432-440
34. Redston M (2001) Carcinogenesis in the GI tract: from morphology to genetics and back again. Mod Pathol 14:236-245
35. Distler P, Holt PR (1997) Are right- and left-sided colon neoplasms distinct tumors? Dig Dis 15:302-311
36. Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260:816-819